FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078422 [Registered on: 23/12/2024] Trial Registered Prospectively
Last Modified On: 18/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A comparative study between two doses of dexmedetomidine 0.5µg/KG and 1µG/kg as an adjuvant to 0.25% ropivacaine in adductor canal block for management of post operative pain in knee surgeries under spinal anaesthesia 
Scientific Title of Study   A comparative study of efficacy and safety of two different doses of dexmedetomidine – 0.5µg/Kg and 1µg/Kg as an adjuvant to 0.25% ropivacaine in ultrasound guided adductor canal block for postoperative analgesia in knee surgeries under spinal anaesthesia 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Ayushi Shastri 
Designation  Junior resident 
Affiliation  MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES, AURANGABAD 
Address  Department of Anaesthesiology, MGM Medical college and hospital N6 CIDCO Aurangabad, Maharashtra, India

Aurangabad
MAHARASHTRA
431003
India 
Phone  8120077366  
Fax    
Email  ayushishastri16@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Pramod Bhale 
Designation  Professor and Head of Department 
Affiliation  MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES, AURANGABAD 
Address  Department of Anaesthesiology, MGM Medical college and hospital N6 CIDCO Aurangabad, Maharashtra, India

Aurangabad
MAHARASHTRA
431003
India 
Phone  8888819021  
Fax    
Email  pramod.bhale@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Pramod Bhale 
Designation  Professor and Head of Department 
Affiliation  MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES, AURANGABAD 
Address  Department of Anaesthesiology, MGM Medical college and hospital N6 CIDCO Aurangabad, Maharashtra, India

Aurangabad
MAHARASHTRA
431003
India 
Phone  8888819021  
Fax    
Email  pramod.bhale@gmail.com  
 
Source of Monetary or Material Support  
MGM Medical college and hospital N6 CIDCO Aurangabad, Maharashtra, India. Pincode- 431003 
 
Primary Sponsor  
Name  MGM Medical college and hospital 
Address  N6 CIDCO Aurangabad, Maharashtra, India pincode- 431003 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ayushi Shastri  MGM hospital  OT no. 6, OT complex Department of Anaesthesiology, MGM Medical college and hospital N6 CIDCO Aurangabad, Maharashtra, India. Pincode 431003
Aurangabad
MAHARASHTRA 
8120077366

ayushishastri16@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
MGM Ethics commitee for research on Human subjects  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M968||Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group RD. Adductor canal block using 0.25% ropivacaine with 0.5µg/kg as an adjuvant.  Patient in supine position with thigh abducted and externally rotated to allow access to medial thigh. Transducer is placed anteromedially at the junction between middle and distal third of thigh. Once femoral artery has been identified, The needle is inserted midplane lateral to medial orientation and advanced towards the femoral artery. When the needle tip is visualised anterior to the artery, once the nerve is visualised clearly, after negative aspiration of blood and spread confirmed, 20ml of 0.25% ropivacaine with 0.5µg/kg as an adjuvant will be given. 
Comparator Agent  Group RD1. Adductor canal block using 0.25% ropivacaine with 1µg/kg as an adjuvant.  Patient in supine position with thigh abducted and externally rotated to allow access to medial thigh. Transducer is placed anteromedially at the junction between middle and distal third of thigh. Once femoral artery has been identified, The needle is inserted midplane lateral to medial orientation and advanced towards the femoral artery. When the needle tip is visualised anterior to the artery, once the nerve is visualised clearly, after negative aspiration of blood and spread confirmed, 20ml of 0.25% ropivacaine with 1µg/kg as an adjuvant will be given. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  posted for elective knee surgeries under spinal anaesthesia
ASA grade II and II 
 
ExclusionCriteria 
Details  Allergy to drugs used in study
Patients having contraindications to adductor canal blocks(local site infections, coagulopathies)
Known neurological deficits 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1. To assess and compare postoperative analgesia using the numerical pain rating scale

2. To assess and compare number of rescue analgesics required within 24hrs 
0 MIN (MOMENT BLOCK IS GIVEN)
30 MIN
60 MIN
90 MIN
120 MIN
6 HOURS
12 HOURS
18 HOURS
24 HOURS 
 
Secondary Outcome  
Outcome  TimePoints 
1. To assess and compare motor blockade between two groups using modified bromage scale
2. To assess and compare haemodynamic parameters
3. To assess and compare sedation score between two groups
4. any adverse effects during first 24 hours post surgery 
0 MIN (MOMENT BLOCK IS GIVEN)
30 MIN
60 MIN
90 MIN
120 MIN
6 HOURS
12 HOURS
18 HOURS
24 HOURS 
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Severe postoperative pain is a common complain post knee surgeries, affecting rehabilitation and early mobilization efforts. Regional anaesthesia forms an important part of the solution. regional anaesthesia specific to lower limb surgeries includes femoral nerve block, sciatic nerve block, obturator nerve block, lumbar plexus block and the adductor canal block. Adductor canal block is superior to femoral nerve block (considered the gold standard) in having an added advantage of motor sparing effect, which eliminates quadriceps weakness and thus helps in early mobilization post operatively. 

In this study, we aim to primarily assess the efficacy of two different doses of dexmedetomidine 0.5mcg/kg and 1mcg/kg as an adjuvant to 0.25% ropivacaine in ultrasound guided adductor canal block in knee surgeries. And compare the number of rescue analgesics needed. Our secondary objective is to compare the motor blockade, sedation scores and hemodynamic stability between the two groups.
 
Close